Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study

[Cancer Management and Research](cancer-management-and-research-journal) » [Volume 14](cancer-management-and-research-archive55-v1655) Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study Authors [Zhang S](author_profile.php?id=1654738)…

Continue Reading Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study

A New Standard for Corticosteroid Dosing for Childhood-Onset SLE with Proliferative Lupus Nephritis

Recently, an international group of pediatric rheumatologists and nephrologists met and created a consensus on a standard for a steroid-dosing regimen to treat childhood-onset systemic lupus erythematosus with proliferative lupus…

Continue Reading A New Standard for Corticosteroid Dosing for Childhood-Onset SLE with Proliferative Lupus Nephritis

Study Determines Cut-off Values for Biomarkers Which Can Increase Risk of Severe Renal Outcomes in Lupus Nephritis

A recent study published in Advances in Rheumatology has uncovered 2 potential biomarkers which could be used to predict which lupus nephritis (LN) patients are at the highest risk of severe renal…

Continue Reading Study Determines Cut-off Values for Biomarkers Which Can Increase Risk of Severe Renal Outcomes in Lupus Nephritis
Tarpeyo Granted Accelerated Approval for IgA Nephropathy
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

Tarpeyo Granted Accelerated Approval for IgA Nephropathy

The FDA has recently granted Accelerated Approval to Tarpeyo, also called budesonide, to reduce proteinuria in patients with IgA nephropathy (IgAN). Tarpeyo is the first and currently the only treatment…

Continue Reading Tarpeyo Granted Accelerated Approval for IgA Nephropathy
Doctors Explain How To Assess Chronic Kidney Disease Staging for Patients
source: pixabay.com

Doctors Explain How To Assess Chronic Kidney Disease Staging for Patients

Dr. Bakris, Dr. Agarwal, Dr. Wright, and Dr. Minkoff have recently come together to discuss how they assess kidney function and ultimately diagnose chronic kidney disease (CKD). Assessing Disease Severity…

Continue Reading Doctors Explain How To Assess Chronic Kidney Disease Staging for Patients
Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients
source: pixabay.com

Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients

Immunoglobulin A nephropathy (IgAN) is a glomerular disease which can lead to kidney failure. Between 70 and 100 percent of all IgAN patients also are diagnosed with microscopic hematuria, but…

Continue Reading Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients
Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
source: pixabay.com

Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis

According to a story from BioSpace, a recent study conducted by the biotechnology company Goldfinch Bio in collaboration with academic partners is highlighting the importance of proteinuria in determining outcomes…

Continue Reading Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN
Photo by Robina Weermeijer on Unsplash

Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN

  According to a press release, biopharmaceutical company Apellis Pharmaceuticals ("Apellis") recently launched registration programs to explore pegcetacoplan for patients with C3 glomerulopathy (C3G), amyotrophic lateral sclerosis (ALS), and immune…

Continue Reading Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN
This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
source: pixabay.com

This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients

Lupus nephritis causes kidney inflammation and can often lead to chronic kidney disease (CKD). An issue that medical professionals have faced is predicting the likelihood of individual patients developing CKD.…

Continue Reading This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available
source: pixabay.com

Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

According to a story from Physician's Weekly, while measuring the concentration of albumin (albuminuria) is widely considered the standard method for staging and screening for chronic kidney disease, a different…

Continue Reading Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

Dosing Begins in Phase 3 IgA Nephropathy Clinical Trial

According to a story from BioSpace, the biopharmaceutical company Retrophin, Inc., recently announced that the first patient has been treated in the company's Phase 3 clinical trial testing sparsentan as…

Continue Reading Dosing Begins in Phase 3 IgA Nephropathy Clinical Trial